Need For Scale, Innovation Driving Asian Pharma M&A
This article was originally published in PharmAsia News
Executive Summary
With cross-border mergers and acquisitions activity in the global health care sector on track to match last year's record, deals involving Asia, and China and India in particular, are seen continuing apace amid rising regional needs for global competitiveness and innovation.